Literature DB >> 26423918

[Omission of osteoporosis diagnostics and therapy after fractures in the elderly : an avoidable treatment error?].

C Neuerburg1, K Heberer2, J Heberer2.   

Abstract

Through a more consistent diagnostics and treatment of osteoporosis, subsequent fractures and associated complications could be reduced in aged patients. Whereas anticoagulants are now standard in the treatment of fractures of the lower extremities to prevent thromboembolic complications in orthopedic surgery and an omission of anticoagulation can be regarded as medical malpractice, the management of osteoporosis following such fractures is very frequently disregarded. Although guidelines for osteoporosis, such as those from the governing body on osteology (Dachverband Osteologie, DVO) from 2014 are not legally binding as such, the breach of this standard of care can constitute a breach of medical obligation by the physician. The omission of osteoporosis diagnostics and initiation of treatment despite appropriate findings after fractures in aged patients, could represent a diagnostic assessment error and severe malpractice in the legal sense. In this case, evidence of a serious malpractice could be associated with civil, criminal and professional claims which could be linked with relevant legal consequences. Regardless of the legal consequences for omission of osteoporosis management following multiple fractures in aged patients, the management of osteoporosis should be an integral component in the treatment of these patients in the future.

Entities:  

Keywords:  Associated complications; Frailty fractures; Medical malpractice; Osteoporosis; Secondary fractures

Mesh:

Year:  2015        PMID: 26423918     DOI: 10.1007/s00113-015-0072-1

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  12 in total

Review 1.  Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.

Authors:  Plamen Kinov; Panayot P Tanchev; Martin Ellis; Gershon Volpin
Journal:  Int Orthop       Date:  2013-10-11       Impact factor: 3.075

2.  Epidemiology, treatment and costs of osteoporosis in Germany--the BoneEVA Study.

Authors:  B Häussler; H Gothe; D Göl; G Glaeske; L Pientka; D Felsenberg
Journal:  Osteoporos Int       Date:  2006-09-19       Impact factor: 4.507

3.  Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.

Authors:  Eugene V McCloskey; Helena Johansson; Anders Oden; Matt Austin; Ethel Siris; Andrea Wang; E Michael Lewiecki; Roman Lorenc; Cesar Libanati; John A Kanis
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

4.  Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.

Authors:  B I Eriksson; K A Bauer; M R Lassen; A G Turpie
Journal:  N Engl J Med       Date:  2001-11-01       Impact factor: 91.245

5.  Oral ibandronate significantly reduces the risk of vertebral fractures of greater severity after 1, 2, and 3 years in postmenopausal women with osteoporosis.

Authors:  D Felsenberg; P Miller; G Armbrecht; K Wilson; R C Schimmer; S E Papapoulos
Journal:  Bone       Date:  2005-08-25       Impact factor: 4.398

6.  Long-term functional outcome in geriatric hip fracture patients.

Authors:  Christian Kammerlander; Markus Gosch; Ursula Kammerlander-Knauer; Thomas J Luger; Michael Blauth; Tobias Roth
Journal:  Arch Orthop Trauma Surg       Date:  2011-04-27       Impact factor: 3.067

7.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors:  Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

8.  Goal-directed treatment of osteoporosis in Europe.

Authors:  J A Kanis; E McCloskey; J Branco; M-L Brandi; E Dennison; J-P Devogelaer; S Ferrari; J-M Kaufman; S Papapoulos; J-Y Reginster; R Rizzoli
Journal:  Osteoporos Int       Date:  2014-09-09       Impact factor: 4.507

Review 9.  Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).

Authors:  E Hernlund; A Svedbom; M Ivergård; J Compston; C Cooper; J Stenmark; E V McCloskey; B Jönsson; J A Kanis
Journal:  Arch Osteoporos       Date:  2013-10-11       Impact factor: 2.617

10.  Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey.

Authors:  Harmen B Ettema; Marieke C Mulder; Michael T Nurmohamed; Harry R Büller; Cees C P M Verheyen
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more
  1 in total

1.  [Interdisciplinary management in geriatric trauma surgery : Results of a survey in Austria].

Authors:  C Stadler; M Gosch; T Roth; C Neuerburg; C Kammerlander
Journal:  Unfallchirurg       Date:  2017-09       Impact factor: 1.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.